169 related articles for article (PubMed ID: 36854028)
1. Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis.
Yogavel M; Bougdour A; Mishra S; Malhotra N; Chhibber-Goel J; Bellini V; Harlos K; Laleu B; Hakimi MA; Sharma A
PLoS Pathog; 2023 Feb; 19(2):e1011124. PubMed ID: 36854028
[TBL] [Abstract][Full Text] [Related]
2. Double drugging of prolyl-tRNA synthetase provides a new paradigm for anti-infective drug development.
Manickam Y; Malhotra N; Mishra S; Babbar P; Dusane A; Laleu B; Bellini V; Hakimi MA; Bougdour A; Sharma A
PLoS Pathog; 2022 Mar; 18(3):e1010363. PubMed ID: 35333915
[TBL] [Abstract][Full Text] [Related]
3. Conformational heterogeneity in apo and drug-bound structures of Toxoplasma gondii prolyl-tRNA synthetase.
Mishra S; Malhotra N; Kumari S; Sato M; Kikuchi H; Yogavel M; Sharma A
Acta Crystallogr F Struct Biol Commun; 2019 Nov; 75(Pt 11):714-724. PubMed ID: 31702585
[TBL] [Abstract][Full Text] [Related]
4. Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis.
Jain V; Yogavel M; Kikuchi H; Oshima Y; Hariguchi N; Matsumoto M; Goel P; Touquet B; Jumani RS; Tacchini-Cottier F; Harlos K; Huston CD; Hakimi MA; Sharma A
Structure; 2017 Oct; 25(10):1495-1505.e6. PubMed ID: 28867614
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel prolyl-tRNA synthetase inhibitor and elucidation of its binding mode to the ATP site in complex with l-proline.
Adachi R; Okada K; Skene R; Ogawa K; Miwa M; Tsuchinaga K; Ohkubo S; Henta T; Kawamoto T
Biochem Biophys Res Commun; 2017 Jun; 488(2):393-399. PubMed ID: 28501621
[TBL] [Abstract][Full Text] [Related]
6. Structure of Prolyl-tRNA Synthetase-Halofuginone Complex Provides Basis for Development of Drugs against Malaria and Toxoplasmosis.
Jain V; Yogavel M; Oshima Y; Kikuchi H; Touquet B; Hakimi MA; Sharma A
Structure; 2015 May; 23(5):819-829. PubMed ID: 25817387
[TBL] [Abstract][Full Text] [Related]
7. Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as
Okaniwa M; Shibata A; Ochida A; Akao Y; White KL; Shackleford DM; Duffy S; Lucantoni L; Dey S; Striepen J; Yeo T; Mok S; Aguiar ACC; Sturm A; Crespo B; Sanz LM; Churchyard A; Baum J; Pereira DB; Guido RVC; Dechering KJ; Wittlin S; Uhlemann AC; Fidock DA; Niles JC; Avery VM; Charman SA; Laleu B
ACS Infect Dis; 2021 Jun; 7(6):1680-1689. PubMed ID: 33929818
[TBL] [Abstract][Full Text] [Related]
8. Computational screening of FDA-approved drugs to identify potential TgDHFR, TgPRS, and TgCDPK1 proteins inhibitors against Toxoplasma gondii.
Gharibi Z; Shahbazi B; Gouklani H; Nassira H; Rezaei Z; Ahmadi K
Sci Rep; 2023 Apr; 13(1):5396. PubMed ID: 37012275
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional analysis of the anti-malarial drug target prolyl-tRNA synthetase.
Jain V; Kikuchi H; Oshima Y; Sharma A; Yogavel M
J Struct Funct Genomics; 2014 Dec; 15(4):181-90. PubMed ID: 25047712
[TBL] [Abstract][Full Text] [Related]
10. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance.
Tye MA; Payne NC; Johansson C; Singh K; Santos SA; Fagbami L; Pant A; Sylvester K; Luth MR; Marques S; Whitman M; Mota MM; Winzeler EA; Lukens AK; Derbyshire ER; Oppermann U; Wirth DF; Mazitschek R
Nat Commun; 2022 Aug; 13(1):4976. PubMed ID: 36008486
[TBL] [Abstract][Full Text] [Related]
12. Assembly of the novel five-component apicomplexan multi-aminoacyl-tRNA synthetase complex is driven by the hybrid scaffold protein Tg-p43.
van Rooyen JM; Murat JB; Hammoudi PM; Kieffer-Jaquinod S; Coute Y; Sharma A; Pelloux H; Belrhali H; Hakimi MA
PLoS One; 2014; 9(2):e89487. PubMed ID: 24586818
[TBL] [Abstract][Full Text] [Related]
13. Identification of Selective Novel Hits against
Nyamai DW; Tastan Bishop Ö
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471245
[TBL] [Abstract][Full Text] [Related]
14. Conformational changes in human prolyl-tRNA synthetase upon binding of the substrates proline and ATP and the inhibitor halofuginone.
Son J; Lee EH; Park M; Kim JH; Kim J; Kim S; Jeon YH; Hwang KY
Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):2136-45. PubMed ID: 24100331
[TBL] [Abstract][Full Text] [Related]
15. Structure-Guided Design of Halofuginone Derivatives as ATP-Aided Inhibitors Against Bacterial Prolyl-tRNA Synthetase.
Cheng B; Cai Z; Luo Z; Luo S; Luo Z; Cheng Y; Yu Y; Guo J; Ju Y; Gu Q; Xu J; Jiang X; Li G; Zhou H
J Med Chem; 2022 Dec; 65(23):15840-15855. PubMed ID: 36394909
[TBL] [Abstract][Full Text] [Related]
16. Structural analyses of the malaria parasite aminoacyl-tRNA synthetases provide new avenues for antimalarial drug discovery.
Chhibber-Goel J; Yogavel M; Sharma A
Protein Sci; 2021 Sep; 30(9):1793-1803. PubMed ID: 34184352
[TBL] [Abstract][Full Text] [Related]
17. A Weak Spot in Multiple Protozoan Parasites.
Wong W
Structure; 2017 Nov; 25(11):1641-1643. PubMed ID: 29117540
[TBL] [Abstract][Full Text] [Related]
18. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.
Herman JD; Pepper LR; Cortese JF; Estiu G; Galinsky K; Zuzarte-Luis V; Derbyshire ER; Ribacke U; Lukens AK; Santos SA; Patel V; Clish CB; Sullivan WJ; Zhou H; Bopp SE; Schimmel P; Lindquist S; Clardy J; Mota MM; Keller TL; Whitman M; Wiest O; Wirth DF; Mazitschek R
Sci Transl Med; 2015 May; 7(288):288ra77. PubMed ID: 25995223
[TBL] [Abstract][Full Text] [Related]
19. The acyl-CoA synthetase
Charital S; Shunmugam S; Dass S; Alazzi AM; Arnold C-S; Katris NJ; Duley S; Quansah NA; Pierrel F; Govin J; Yamaryo-Botté Y; Botté CY
mBio; 2024 Apr; 15(4):e0042724. PubMed ID: 38501871
[TBL] [Abstract][Full Text] [Related]
20. Structural characterization of glutamyl-tRNA synthetase (GluRS) from Plasmodium falciparum.
Sharma VK; Chhibber-Goel J; Yogavel M; Sharma A
Mol Biochem Parasitol; 2023 Feb; 253():111530. PubMed ID: 36370911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
